Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains

Vaccine

Volumn 23, Issue 38, 2005, Pages 4658-4665

  Chang, Yueh J ^a   Jiang, Ming ^a   Lubinski, John M ^a   King, Ryan D ^a   Friedman, Harvey M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

HSV 1; Immune evasion; Immunization

Indexed keywords

COMPLEMENT COMPONENT C3B; GLYCOPROTEIN GC 1; HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BINDING AFFINITY; COMPLEMENT ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; HERPESVIRIDAE INFECTIONS; MICE; MICE, INBRED BALB C; SIMPLEXVIRUS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 23644444117     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.04.034     Document Type: Article

References (43)

1. T.H. Mogensen, J. Melchjorsen, L. Malmgaard, A. Casola, and S.R. Paludan Suppression of proinflammatory cytokine expression by herpes simplex virus type 1 J Virol 78 11 2004 5883 5890
2. A. Hill, P. Jugovic, I. York, G. Russ, J. Bennink, and J. Yewdell Herpes simplex virus turns off the TAP to evade host immunity Nature 375 6530 1995 411 415
3. J. Neumann, A.M. Eis-Hubinger, and N. Koch Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion J Immunol 171 6 2003 3075 3083
4. I. Frank, and H.M. Friedman Progress in the treatment of cytomegalovirus pneumonia Ann Internal Med 109 10 1988 769 771
5. R. Tal-Singer, C. Seidel-Dugan, L. Fries, H.P. Huemer, R.J. Eisenberg, and G.H. Cohen Herpes simplex virus glycoprotein C is a receptor for complement component iC3b J Infect Dis 164 4 1991 750 753
6. I. Kostavasili, A. Sahu, H.M. Friedman, R.J. Eisenberg, G.H. Cohen, and J.D. Lambris Mechanism of complement inactivation by glycoprotein C of herpes simplex virus J Immunol 158 4 1997 1763 1771
7. L.F. Fries, H.M. Friedman, G.H. Cohen, R.J. Eisenberg, C.H. Hammer, and M.M. Frank Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade J Immunol 137 5 1986 1636 1641
8. S.L. Hung, C. Peng, I. Kostavasili, H.M. Friedman, J.D. Lambris, and R.J. Eisenberg The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway Virology 203 2 1994 299 312
9. N. Rawal, and M.K. Pangburn Formation of high affinity C5 convertase of the classical pathway of complement J Biol Chem 278 40 2003 38476 38483
10. Pangburn MK, Rawal N, Structure and function of complement C5 convertase enzymes. Biochem Soc Trans, 1006 30(Pt 6), 1006-10.
11. H.M. Friedman, G.H. Cohen, R.J. Eisenberg, C.A. Seidel, and D.B. Cines Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells Nature 309 5969 1984 633 635
12. Y.T. Chen, Y.H. Wang, Y.Y. Cheng, and S.L. Hung Direct binding of herpes simplex virus type 1 virions to complement C3 Viral Immunol 16 3 2003 347 355
13. H.M. Friedman, L. Wang, N.O. Fishman, J.D. Lambris, R.J. Eisenberg, and G.H. Cohen Immune evasion properties of herpes simplex virus type 1 glycoprotein gC J Virol 70 7 1996 4253 4260
14. T.A. McNearney, C. Odell, V.M. Holers, P.G. Spear, and J.P. Atkinson Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity J Exper Med 166 5 1987 1525 1535
15. S.L. Harris, I. Frank, A. Yee, G.H. Cohen, R.J. Eisenberg, and H.M. Friedman Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization J Infect Dis 162 2 1990 331 337
16. S.L. Hung, S. Srinivasan, H.M. Friedman, R.J. Eisenberg, and G.H. Cohen Structural basis of C3b binding by glycoprotein C of herpes simplex virus J Virol 66 7 1992 4013 4027
17. J. Lubinski, L. Wang, D. Mastellos, A. Sahu, J.D. Lambris, and H.M. Friedman In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC J Exper Med 190 11 1999 1637 1646
18. D.M. Koelle, and L. Corey Recent progress in herpes simplex virus immunobiology and vaccine research Clin Microbiol Rev 16 1 2003 96 113
19. I.A. York, C. Roop, D.W. Andrews, S.R. Riddell, F.L. Graham, and D.C. Johnson A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes Cell 77 4 1994 525 535
20. K.A. Judson, J.M. Lubinski, M. Jiang, Y. Chang, R.J. Eisenberg, and G.H. Cohen Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection J Virol 77 23 2003 12639 12645
21. H.M. Friedman, E.J. Macarak, R.R. MacGregor, J. Wolfe, and N.A. Kefalides Virus infection of endothelial cells J Infect Dis 143 2 1981 266 273
22. R. Tal-Singer, C. Peng, M. Ponce De Leon, W.R. Abrams, B.W. Banfield, and F. Tufaro Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules J Virol 69 7 1995 4471 4483
23. L.R. Stanberry, S.L. Spruance, A.L. Cunningham, D.I. Bernstein, A. Mindel, and S. Sacks Glycoprotein-D-adjuvant vaccine to prevent genital herpes N Engl J Med 347 21 2002 1652 1661
24. H.M. Friedman, L. Wang, M.K. Pangburn, J.D. Lambris, and J. Lubinski Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1 J Immunol 165 8 2000 4528 4536
25. M.L. Smiley, J.A. Hoxie, and H.M. Friedman Herpes simplex virus type 1 infection of endothelial, epithelial, and fibroblast cells induces a receptor for C3b J Immunol 134 4 1985 2673 2678
26. M.L. Smiley, and H.M. Friedman Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells J Virol 55 3 1985 857 861
27. D.B. Cines, A.P. Lyss, M. Bina, R. Corkey, N.A. Kefalides, and H.M. Friedman Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells J Clin Invest 69 1 1982 123 128
28. J.M. Lubinski, L. Wang, A.M. Soulika, R. Burger, R.A. Wetsel, and H. Colten Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo J Virol 72 10 1998 8257 8263
29. H.M. Friedman Immunologic strategies for herpes vaccination J Am Med Assoc 283 6 2000 746 747
30. A.H. Rux, W.T. Moore, J.D. Lambris, W.R. Abrams, C. Peng, and H.M. Friedman Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus J Virol 70 8 1996 5455 5465
31. C.M. Dobson Principles of protein folding, misfolding and aggregation Sem Cell Develop Biol 15 1 2004 3 16
32. S.N. Isaacs, G.J. Kotwal, and B. Moss Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence Proc Nat Acad Sci USA 89 2 1992 628 632
33. G.J. Kotwal, and B. Moss Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins Nature 335 6186 1988 176 178
34. S.B. Kapadia, B. Levine, S.H. Speck, and H.W. Virgin Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection Immunity 17 2 2002 143 155
35. J.C. Albrecht, and B. Fleckenstein New member of the multigene family of complement control proteins in herpesvirus saimiri J Virol 66 6 1992 3937 3940
36. R.P. Rother, S.A. Rollins, W.L. Fodor, J.C. Albrecht, E. Setter, and B. Fleckenstein Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri J Virol 68 2 1994 730 737
37. J.J. Russo, R.A. Bohenzky, M.C. Chien, J. Chen, M. Yan, and D. Maddalena Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) Proc Natl Acad Sci USA 93 25 1996 14862 14867
38. J. Mullick, J. Bernet, A.K. Singh, J.D. Lambris, and A. Sahu Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins J Virol 77 6 2003 3878 3881
39. R.W. Doms, and J.P. Moore HIV-1 membrane fusion: targets of opportunity J Cell Biol 151 2 2000 16
40. P.D. Kwong, M.L. Doyle, D.J. Casper, C. Cicala, S.A. Leavitt, and S. Majeed HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites Nature 420 6916 2002 678 682
41. X. Wei, J.M. Decker, and S. Wang Antibody neutralization and escape by HIV-1 Nature 422 6929 2003 307 312
42. J.N. Reitter, R.E. Means, and R.C. Desrosiers A role for carbohydrates in immune evasion in AIDS Nature Med 4 6 1998 679 684
43. A.H. Rux, H. Lou, J.D. Lambris, H.M. Friedman, R.J. Eisenberg, and G.H. Cohen Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b Virology 294 2 2002 324 332